Cutting Edge: Mast Cells Express IL-17A in Rheumatoid Arthritis Synovium
Cutting Edge: Mast Cells Express IL-17A in Rheumatoid Arthritis Synovium
复制标题
DOI:
10.4049/jimmunol.0903566
复制
发表时间:
2010-04-01
影响因子:
4.4
通讯作者:
McInnes, Iain B.
中科院分区:
文献类型:
--
作者:
Hueber, Axel J.;Asquith, Darren L.;McInnes, Iain B.
The proinflammatory cytokine IL-17A is considered a crucial player in rheumatoid arthritis (RA) pathogenesis. In experimental models of autoimmune arthritis, it has been suggested that the cellular source of IL-17A is CD4(+) T cells (Th17 cells). However, little is known about the source of IL-17 in human inflamed RA tissue. We explored the cellular sources of IL-17A in human RA synovium. Surprisingly, only a small proportion of IL-17-expressing cells were T cells, and these were CCR6 negative. Unexpectedly, the majority of IL-17A expression colocalized within mast cells. Furthermore, we demonstrated in vitro that mast cells produced RORC-dependent IL-17A upon stimulation with TNF-alpha, IgG complexes, C5a, and LPS. These data a-re consistent with a crucial role for IL-17A in RA pathogenesis but suggest that in addition to T cells innate immune pathways particularly mediated via mast cells may be an important component of the effector IL-17A response. The Journal of Immunology, 2010, 184: 3336-3340.